▁ 4.109375
8 3.849609375
% 6.42578125
▁of 1.0673828125
▁the 2.35546875
▁residents 6.44921875
▁of 0.7294921875
▁progress 12.59375
ive 0.04425048828125
▁countries 6.578125
▁still 5.21875
▁consider 4.0703125
▁chron 11.2265625
ic 0.08221435546875
▁pain 1.9501953125
▁to 1.2685546875
▁be 0.0180816650390625
▁an 2.517578125
▁extreme 7.578125
▁issue 4.4296875
. 0.9072265625
▁The 2.525390625
▁introduction 7.03515625
▁of 0.029205322265625
▁the 2.119140625
▁study 7.421875
▁describes 7.71875
▁the 0.724609375
▁apparent 8.75
▁link 5.08984375
▁between 0.1365966796875
▁pain 2.4296875
▁and 0.290771484375
▁dem 6.95703125
oral 3.248046875
ization 0.1341552734375
. 0.92041015625
▁Chron 4.1484375
ic 0.003162384033203125
▁pain 0.124267578125
▁is 1.078125
▁always 6.09765625
▁accompanied 2.79296875
▁by 0.021484375
▁negative 4.09765625
▁emot 0.66357421875
ional 1.61328125
▁experiences 2.380859375
▁and 2.162109375
▁blocks 10.2734375
▁a 3.1640625
▁person 0.367431640625
’ 0.7900390625
s 0.0004019737243652344
▁ability 1.306640625
▁to 0.016632080078125
▁receive 6.64453125
▁joy 3.345703125
▁and 1.5361328125
▁satisfaction 2.962890625
▁from 0.787109375
▁life 0.53662109375
. 0.1634521484375
▁The 2.216796875
▁research 2.724609375
▁investig 7.46484375
ates 0.7939453125
▁the 0.50439453125
▁development 5.65625
▁of 0.1270751953125
▁de 4.4453125
pression 0.409912109375
▁and 1.431640625
▁anx 1.2822265625
iety 0.0005326271057128906
▁among 2.26171875
▁patients 1.46484375
▁receiving 5.8203125
▁ph 5.48828125
arma 3.24609375
ce 0.0095367431640625
ut 0.00038051605224609375
ical 0.0026035308837890625
▁op 4.5546875
io 0.0819091796875
ids 0.348876953125
▁and 2.580078125
▁medical 3.609375
▁mar 1.64453125
iju 0.0008969306945800781
ana 4.303455352783203e-05
▁( 3.478515625
MM 1.61328125
) 3.046875
▁as 2.859375
▁severe 9.9296875
▁pain 0.712890625
kill 2.4375
ers 0.0004794597625732422
. 0.19189453125
▁It 3.625
▁comp 4.82421875
ares 0.005542755126953125
▁the 0.5908203125
▁effic 4.10546875
acy 0.0010118484497070312
▁of 0.2064208984375
▁pres 6.140625
cri 2.01953125
ptions 1.3798828125
▁and 1.9306640625
▁exam 4.65234375
ines 0.009002685546875
▁the 0.446044921875
▁possibility 3.90625
▁of 0.05328369140625
▁post 8.09375
- 0.59619140625
tre 1.978515625
at 0.0009489059448242188
ment 0.0020313262939453125
▁de 1.8037109375
pression 0.07452392578125
. 1.1416015625
▁There 6.00390625
▁is 1.044921875
▁currently 5.27734375
▁a 1.23046875
▁severe 4.91796875
▁lack 2.0703125
▁of 0.0108489990234375
▁information 2.025390625
▁about 1.279296875
▁the 0.548828125
▁effects 3.0546875
▁of 0.0596923828125
▁op 3.37109375
i 3.3828125
ates 0.0142364501953125
. 3.083984375
▁They 5.23046875
▁manage 8.3046875
▁pain 2.876953125
▁successfully 6.0390625
, 0.818359375
▁but 0.1629638671875
▁the 2.46875
▁past 9.109375
▁few 1.9091796875
▁dec 1.3037109375
ades 1.537799835205078e-05
▁indicated 8.359375
▁the 1.880859375
▁growing 3.69140625
▁concern 3.734375
▁regarding 2.939453125
▁op 2.4140625
iate 1.234375
▁ab 1.51171875
use 0.01104736328125
▁in 3.8515625
▁forms 9.609375
▁of 0.3203125
▁over 3.150390625
d 0.0985107421875
ose 0.282470703125
▁and 0.6787109375
▁add 0.65283203125
iction 0.015838623046875
. 0.099365234375
▁A 4.3046875
▁more 4.875
▁manage 7.91796875
able 0.0005559921264648438
▁and 2.03515625
▁sa 2.046875
fer 9.47713851928711e-05
▁alternative 1.2626953125
▁might 5.390625
▁be 0.125244140625
▁medical 1.7431640625
▁mar 0.215087890625
iju 0.0007424354553222656
ana 0.00012433528900146484
. 0.7373046875
▁However 4.046875
, 0.004352569580078125
▁the 1.7216796875
▁legal 4.015625
▁status 1.0732421875
▁and 3.033203125
▁novel 9.671875
ty 0.1341552734375
▁of 0.134033203125
▁this 2.40625
▁drug 1.546875
▁do 4.59375
▁not 0.01312255859375
▁allow 0.68115234375
▁finding 7.10546875
▁a 2.3359375
▁large 2.6171875
▁number 0.853515625
▁of 0.00247955322265625
▁studies 1.1669921875
▁on 1.64453125
▁its 0.78857421875
▁effect 2.298828125
iveness 0.2369384765625
. 0.63330078125
▁Specifically 9.078125
, 0.047882080078125
▁it 2.75390625
▁concerns 5.25390625
▁the 0.8779296875
▁emot 6.5390625
ional 0.017364501953125
▁condition 4.5234375
▁of 0.21044921875
▁patients 0.6337890625
▁experien 5.4140625
cing 6.80685043334961e-05
▁chron 0.767578125
ic 0.00044083595275878906
▁pain 0.0518798828125
. 0.414794921875
▁This 2.912109375
▁research 1.9580078125
▁paper 4.2578125
▁a 1.8408203125
ims 0.0003807544708251953
▁to 0.08575439453125
▁analyze 3.142578125
▁levels 10.125
▁of 0.0235595703125
▁de 0.50146484375
pression 0.0251922607421875
▁and 0.19775390625
▁anx 0.02703857421875
iety 0.00039005279541015625
▁among 0.87109375
▁people 2.6953125
▁receiving 2.279296875
▁ther 6.578125
apy 0.10064697265625
▁by 4.640625
▁comparing 7.99609375
▁the 1.4775390625
▁effects 2.11328125
▁of 0.02630615234375
▁ph 2.998046875
arma 0.029083251953125
ce 0.0035076141357421875
ut 0.00014412403106689453
ical 0.0031719207763671875
▁op 0.11444091796875
io 0.54248046875
ids 0.034515380859375
▁and 0.2347412109375
▁MM 0.481201171875
. 0.298095703125
▁The 1.40234375
▁study 1.875
▁was 3.658203125
▁conducted 0.65283203125
▁in 1.193359375
▁the 1.4111328125
▁form 2.931640625
▁of 0.0022487640380859375
▁collection 11.921875
▁and 0.7109375
▁analysis 0.41015625
▁of 0.01119232177734375
▁statistical 3.61328125
▁data 0.127197265625
. 1.095703125
▁Part 5.52734375
icip 0.1865234375
ants 0.05877685546875
▁were 0.78662109375
▁rec 3.931640625
ru 0.0010776519775390625
ited 0.00017774105072021484
▁for 4.2109375
▁six 6.88671875
▁months 0.4111328125
▁at 3.90234375
▁two 2.603515625
▁major 4.11328125
▁pain 2.517578125
▁relief 4.02734375
▁cent 0.82958984375
ers 0.03826904296875
▁in 0.59521484375
▁Israel 5.3671875
. 0.3408203125
▁The 1.162109375
▁research 2.42578125
ers 1.7490234375
▁used 2.17578125
▁The 6.8125
▁De 3.072265625
pression 0.0224456787109375
▁Module 6.93359375
▁of 0.8037109375
▁the 0.233154296875
▁Pat 3.306640625
ient 0.00994873046875
▁Health 0.03155517578125
▁Question 0.0192108154296875
naire 0.0229644775390625
▁and 2.583984375
▁the 0.88525390625
▁General 1.169921875
ized 0.59619140625
▁An 0.0049896240234375
x 9.322166442871094e-05
iety 0.00043463706970214844
▁Dis 0.1861572265625
order 0.0203094482421875
▁Sc 1.400390625
ale 0.0031070709228515625
▁to 0.91943359375
▁interview 7.74609375
▁participants 2.55078125
, 4.3203125
▁evaluate 4.5078125
▁their 0.61083984375
▁answers 3.994140625
, 0.3134765625
▁and 0.038543701171875
▁conduct 4.859375
▁the 1.9140625
▁study 2.142578125
. 0.07696533203125
▁To 5.04296875
▁specifically 10.5234375
▁evaluate 3.044921875
▁and 4.96484375
▁compare 0.53076171875
▁the 0.381103515625
▁prob 9.9609375
abilities 0.0584716796875
▁of 0.068115234375
▁de 0.84912109375
pression 0.034820556640625
▁or 4.37109375
▁anx 0.048431396484375
iety 0.0005545616149902344
▁among 1.462890625
▁the 2.078125
▁diverse 9.8671875
▁groups 0.86083984375
, 0.78515625
▁the 0.433837890625
▁study 2.533203125
▁used 1.3955078125
▁multiple 5.3125
▁log 0.493408203125
istic 0.024169921875
▁regression 0.264892578125
▁analysis 1.3447265625
▁and 2.74609375
▁chose 8.5859375
▁medical 6.19921875
▁mar 0.089599609375
iju 0.0009927749633789062
ana 4.291534423828125e-05
▁as 0.478515625
▁the 0.76806640625
▁control 2.724609375
▁group 0.59228515625
. 0.26025390625
▁This 3.615234375
▁type 4.52734375
▁of 0.004474639892578125
▁study 2.78515625
▁is 1.490234375
▁the 3.62890625
▁most 1.208984375
▁reve 8.265625
aling 0.000713348388671875
▁and 1.5458984375
▁inclus 7.15625
ive 0.0008678436279296875
, 2.505859375
▁as 1.232421875
▁it 0.27099609375
▁contains 5.19140625
▁direct 6.8984375
▁responses 5.51171875
▁from 0.7958984375
▁a 3.734375
▁large 1.1220703125
▁number 0.51708984375
▁of 0.002838134765625
▁participants 0.98974609375
. 0.7666015625
▁All 5.3125
▁tools 8.0546875
▁in 5.06640625
▁the 0.6015625
▁form 5.734375
▁of 0.033782958984375
▁question 0.74609375
na 0.01195526123046875
ires 0.00022900104522705078
▁and 1.35546875
▁scales 2.765625
▁have 3.228515625
▁already 4.58984375
▁been 0.354736328125
▁used 2.369140625
▁and 1.77734375
▁proved 2.59765625
▁their 1.3583984375
▁effic 2.642578125
acy 0.0029296875
▁for 3.626953125
▁collect 4.0
ing 0.003978729248046875
▁analyt 7.171875
ical 0.0941162109375
▁data 0.182861328125
. 0.364501953125
▁It 3.830078125
▁is 1.033203125
▁helpful 6.71875
▁to 0.6142578125
▁system 8.28125
at 0.7431640625
ize 0.0025310516357421875
▁and 1.615234375
▁class 4.546875
ify 0.0015287399291992188
▁different 5.04296875
▁kinds 4.17578125
▁of 0.01555633544921875
▁information 2.404296875
. 1.2421875
▁Thus 4.40234375
, 0.0114898681640625
▁research 4.25390625
ers 0.1893310546875
▁can 1.24609375
▁compare 2.373046875
▁the 1.2890625
▁effects 3.53125
▁of 0.15185546875
▁medic 3.771484375
ations 0.6650390625
▁on 1.5927734375
▁patients 1.9921875
▁of 4.265625
▁diverse 3.236328125
▁age 1.95703125
▁groups 2.31640625
, 0.66943359375
▁background 3.830078125
s 0.11297607421875
, 0.0161285400390625
▁physical 5.60546875
▁conditions 1.2265625
, 0.03546142578125
▁emot 6.34375
ional 0.024200439453125
▁states 1.2548828125
, 0.04681396484375
▁and 0.396484375
▁so 2.61328125
▁on 0.16162109375
. 0.042327880859375
▁The 0.9599609375
▁analysis 3.642578125
▁of 0.9384765625
▁any 8.4609375
▁human 6.7734375
▁reaction 3.828125
▁has 4.80859375
▁a 1.779296875
▁high 3.134765625
▁potential 3.271484375
▁of 2.1875
▁subject 3.650390625
iveness 3.76171875
▁and 1.2431640625
▁bias 1.6552734375
, 1.658203125
▁especially 2.810546875
▁regarding 3.65234375
▁people 4.86328125
▁in 3.7421875
▁severe 2.58203125
▁pain 0.5263671875
▁and 2.341796875
▁un 5.92578125
stable 0.90478515625
▁emot 0.642578125
ional 0.08154296875
▁condition 2.40234375
. 0.051483154296875
▁Perhaps 8.9765625
▁some 5.234375
▁patients 1.9755859375
▁tend 4.6484375
▁to 0.0093841552734375
▁ex 1.92578125
agger 0.00897979736328125
ate 0.0011453628540039062
▁their 0.90478515625
▁de 3.068359375
press 1.8525390625
ive 0.0595703125
▁state 2.40625
▁or 1.6181640625
▁vice 5.8671875
▁vers 0.02301025390625
a 2.765655517578125e-05
, 1.0634765625
▁de 7.40625
- 2.515625
emph 0.405517578125
as 0.0018415451049804688
ize 0.050048828125
▁serious 6.73046875
▁difficulties 5.55859375
. 0.72265625
▁Because 6.2734375
▁the 2.90625
▁survey 4.9609375
▁responses 6.58203125
▁were 1.4580078125
▁thoroughly 8.390625
▁anonymous 3.08203125
, 0.274658203125
▁the 1.0986328125
▁research 0.9248046875
ers 0.16259765625
▁were 2.3359375
▁unable 3.36328125
▁to 0.0016384124755859375
▁carefully 7.9453125
▁analyze 2.62890625
▁each 2.421875
▁patient 2.455078125
’ 0.56396484375
s 0.0010271072387695312
▁reaction 4.01953125
▁and 1.3759765625
▁compare 3.6328125
▁it 0.85107421875
▁to 0.53564453125
▁the 1.0107421875
▁actual 4.38671875
▁states 7.82421875
▁of 0.57177734375
▁condition 7.10546875
. 0.3798828125
▁More 6.05078125
▁accurate 3.26953125
▁answers 4.5390625
▁could 1.822265625
▁be 0.66455078125
▁obtained 1.001953125
▁by 1.443359375
▁professional 6.14453125
▁psych 1.0732421875
olog 0.39697265625
ists 0.0011854171752929688
▁via 7.3515625
▁personal 2.62890625
▁communication 4.5390625
▁and 1.9765625
▁behavior 6.30859375
al 0.262451171875
▁analysis 2.08203125
. 0.2724609375
▁However 1.505859375
, 0.0005254745483398438
▁this 1.5029296875
▁method 2.240234375
▁of 2.3828125
▁research 1.919921875
▁is 1.0556640625
▁way 6.25
▁more 0.9267578125
▁resource 4.4375
- 0.302978515625
int 1.416015625
ensive 0.0204315185546875
▁and 0.430419921875
▁energy 10.84375
- 0.07110595703125
consum 0.35546875
ing 0.0012388229370117188
. 0.67822265625
▁Part 6.2265625
icip 0.322265625
ants 0.1656494140625
▁were 1.6337890625
▁rec 2.314453125
ru 0.0004143714904785156
ited 1.33514404296875e-05
▁for 2.009765625
▁six 0.32861328125
▁months 0.005527496337890625
▁at 0.398681640625
▁two 0.07489013671875
▁major 0.10589599609375
▁pain 0.031768798828125
▁relief 0.0256195068359375
▁cent 0.01390838623046875
ers 0.0007138252258300781
▁in 0.04217529296875
▁Israel 0.0134124755859375
. 0.15966796875
▁All 3.63671875
▁patients 1.8515625
▁experienced 4.515625
▁chron 0.73779296875
ic 0.00016200542449951172
▁pain 0.153076171875
▁for 2.556640625
▁at 0.85986328125
▁least 0.0016469955444335938
▁ 2.048828125
3 1.4541015625
▁months 0.225341796875
. 1.1923828125
▁The 1.3115234375
▁study 1.8193359375
▁included 1.646484375
▁ 0.6201171875
8 2.9921875
9 2.5078125
0 3.009765625
▁participants 1.5068359375
, 1.4658203125
▁of 2.66015625
▁which 0.4072265625
▁ 0.09271240234375
4 1.236328125
7 2.646484375
4 2.61328125
▁( 3.13671875
5 0.08721923828125
9 4.9296875
%) 0.75732421875
▁were 0.76953125
▁treated 3.228515625
▁sole 6.67578125
ly 5.984306335449219e-05
▁with 0.275146484375
▁op 1.421875
io 0.347412109375
ids 0.1351318359375
, 0.53076171875
▁ 0.7548828125
3 1.19921875
2 2.236328125
9 2.47265625
▁( 0.042694091796875
4 2.451171875
1 1.1484375
%) 0.053070068359375
▁were 1.431640625
▁treated 0.5224609375
▁with 0.421630859375
▁MM 0.5595703125
, 0.38427734375
▁and 0.09503173828125
▁ 0.21533203125
7 1.8603515625
7 2.580078125
▁( 0.09930419921875
8 1.953125
. 0.9423828125
6 2.349609375
%) 0.0755615234375
▁acquired 10.671875
▁both 0.58251953125
▁( 4.96875
Fe 9.5
ing 1.3837890625
old 0.359375
▁et 1.015625
▁al 0.027069091796875
., 0.197265625
▁ 0.01271820068359375
2 0.00853729248046875
0 0.0004334449768066406
1 0.339111328125
7 1.70703125
). 0.05548095703125
▁The 0.93115234375
▁remaining 7.9375
▁ten 6.6171875
▁participants 1.287109375
▁who 5.046875
▁did 2.408203125
▁not 0.00608062744140625
▁receive 2.1328125
▁ph 3.845703125
arma 0.0916748046875
ce 0.0007662773132324219
ut 2.9802322387695312e-06
ical 0.0023097991943359375
▁op 1.4765625
io 0.046783447265625
ids 0.02423095703125
▁and 2.521484375
▁medical 1.6796875
▁mar 0.03936767578125
iju 0.00022602081298828125
ana 4.0411949157714844e-05
▁were 0.49462890625
▁with 6.7890625
dra 0.053253173828125
wn 6.866455078125e-05
▁from 0.21875
▁the 0.173828125
▁analysis 2.33984375
▁in 5.015625
▁the 1.1806640625
▁research 4.2578125
. 1.171875
▁Therefore 4.91796875
, 0.01276397705078125
▁it 3.84375
▁is 1.0205078125
▁not 2.80078125
▁possible 0.67626953125
▁to 0.00792694091796875
▁compreh 5.91796875
ens 0.07940673828125
ively 0.0154266357421875
▁compare 1.3115234375
▁patients 5.12890625
▁taking 3.7421875
▁medic 4.26171875
ations 0.58642578125
▁with 1.44921875
▁those 1.1240234375
▁who 0.79052734375
▁do 1.3837890625
▁not 0.004428863525390625
. 0.57666015625
▁The 1.369140625
▁study 1.78125
▁conducted 4.3359375
▁a 1.755859375
▁correlation 6.4609375
▁type 9.3515625
▁of 0.2440185546875
▁research 0.859375
▁with 3.57421875
▁variable 8.6328125
▁measures 5.1484375
. 0.8701171875
▁It 1.6796875
▁evaluated 4.76953125
▁the 0.61572265625
▁inter 6.1796875
dep 2.42578125
end 0.00021922588348388672
ence 0.007183074951171875
▁of 0.564453125
▁various 3.470703125
▁factors 0.8330078125
▁that 2.986328125
▁affected 4.08984375
▁the 0.439453125
▁physical 6.2734375
▁and 0.248046875
▁emot 0.41796875
ional 9.036064147949219e-05
▁condition 1.384765625
▁of 0.034454345703125
▁patients 0.7236328125
▁experien 2.904296875
cing 1.9073486328125e-06
▁chron 0.2127685546875
ic 0.00015628337860107422
▁pain 0.009063720703125
. 0.1270751953125
▁For 4.19921875
▁example 1.0224609375
, 0.001743316650390625
▁the 1.0458984375
▁survey 5.546875
▁showed 4.09765625
▁that 0.4736328125
▁the 1.89453125
▁ratio 6.78515625
▁of 0.07208251953125
▁female 3.4375
▁patients 0.88720703125
▁was 1.3095703125
▁remark 8.1015625
ably 0.00016069412231445312
▁higher 0.1689453125
▁in 2.32421875
▁the 0.426513671875
▁op 3.908203125
i 3.62890625
ates 0.01348114013671875
▁group 0.20166015625
▁compared 2.5
▁to 0.035736083984375
▁the 0.56591796875
▁MM 0.1514892578125
▁group 0.2900390625
. 0.434814453125
▁In 3.484375
▁turn 4.44140625
, 0.001087188720703125
▁people 4.8671875
▁on 4.7421875
▁op 3.0546875
i 0.646484375
ates 0.0035114288330078125
▁were 0.916015625
▁more 1.390625
▁likely 0.257080078125
▁to 0.024627685546875
▁report 2.91796875
▁major 6.02734375
▁de 0.46240234375
press 0.69482421875
ive 0.0021228790283203125
▁dis 0.89111328125
orders 1.6640625
. 1.5458984375
▁The 1.6318359375
▁question 5.43359375
na 1.0908203125
ires 0.0002181529998779297
▁used 2.578125
▁different 6.828125
▁variable 8.109375
▁measures 0.29638671875
▁to 1.927734375
▁collect 2.439453125
▁information 1.5615234375
. 1.291015625
▁For 1.552734375
▁example 0.259521484375
, 0.0017595291137695312
▁it 4.1015625
▁included 2.150390625
▁compreh 8.296875
ensive 0.04156494140625
▁so 5.48046875
cio 0.0007381439208984375
- 0.28125
dem 0.1324462890625
ographic 0.0718994140625
▁data 0.9091796875
: 4.75
▁gender 2.0859375
, 0.040771484375
▁age 0.27490234375
, 0.037078857421875
▁country 4.0625
, 2.66015625
▁type 4.46484375
▁of 0.05682373046875
▁residence 4.08203125
▁( 2.55078125
urban 0.7294921875
/ 1.3828125
r 0.1588134765625
ural 0.0008654594421386719
), 0.1766357421875
▁years 6.37890625
▁of 0.1724853515625
▁education 0.73779296875
, 0.086669921875
▁and 1.4892578125
▁employ 2.544921875
ment 0.0016355514526367188
▁status 0.63427734375
. 0.17041015625
▁Pat 4.44921875
ients 0.08087158203125
▁were 1.267578125
▁also 0.89990234375
▁asked 0.51025390625
▁about 1.0224609375
▁their 0.6435546875
▁medical 2.466796875
▁history 0.587890625
▁over 8.859375
▁the 0.0616455078125
▁years 4.5859375
▁and 1.6943359375
▁the 1.5009765625
▁current 2.890625
▁presence 5.21484375
▁of 0.083251953125
▁any 2.259765625
▁severe 3.466796875
▁dise 1.8291015625
ases 6.520748138427734e-05
▁such 4.33203125
▁as 0.0010881423950195312
▁heart 2.52734375
▁failure 1.7412109375
, 0.299560546875
▁di 1.6162109375
ab 0.0006060600280761719
etes 0.002292633056640625
, 0.060333251953125
▁ar 4.16796875
th 0.138427734375
rit 0.02288818359375
is 0.003704071044921875
, 0.027679443359375
▁and 1.2216796875
▁so 0.81494140625
▁on 0.046630859375
. 0.050140380859375
▁The 1.388671875
▁third 7.12109375
▁measure 3.59765625
▁of 2.109375
▁the 0.50244140625
▁question 2.029296875
naire 0.309326171875
▁was 1.109375
▁indicated 10.8046875
▁by 1.1240234375
▁information 6.76171875
▁on 2.06640625
▁any 5.63671875
▁twelve 14.328125
- 0.23974609375
month 0.1627197265625
▁and 5.0
▁lifetime 0.62353515625
▁drug 3.2421875
▁and 1.6640625
▁alco 0.133544921875
hol 6.282329559326172e-05
▁consumption 4.7578125
. 0.3955078125
▁In 3.22265625
▁addition 1.0791015625
, 0.31787109375
▁the 0.912109375
▁record 10.2734375
▁included 1.3544921875
▁a 2.744140625
▁pain 4.53125
▁measurement 5.00390625
▁scale 0.78125
▁from 4.4140625
▁ 0.54638671875
0 0.2919921875
▁to 0.241455078125
▁ 0.00644683837890625
1 0.0716552734375
0 0.035247802734375
▁to 3.28125
▁evaluate 1.4091796875
▁dis 6.16015625
com 0.1295166015625
fort 0.001743316650390625
▁feelings 8.296875
▁during 4.171875
▁the 0.260009765625
▁last 0.98095703125
▁month 1.7001953125
. 0.2294921875
▁Among 6.09765625
▁all 2.4453125
▁participants 2.322265625
▁in 4.0390625
▁the 0.1942138671875
▁study 0.499755859375
, 0.033905029296875
▁ 0.7275390625
4 1.869140625
2 2.33984375
. 1.1787109375
2 2.22265625
% 0.0631103515625
▁suffered 3.759765625
▁from 0.06597900390625
▁de 2.087890625
pression 0.294189453125
, 0.91064453125
▁and 1.2275390625
▁ 0.11279296875
3 1.4931640625
7 2.365234375
% 2.595703125
▁experienced 1.98046875
▁excess 6.89453125
ive 0.0243682861328125
▁anx 0.247802734375
iety 0.001674652099609375
. 0.397216796875
▁The 1.390625
▁pl 11.0
ur 0.79736328125
ality 0.0011034011840820312
▁of 0.101318359375
▁de 2.4609375
press 1.232421875
ive 0.0252532958984375
▁dis 2.314453125
orders 0.07513427734375
▁among 3.09765625
▁patients 1.0380859375
▁in 2.76953125
▁the 0.27490234375
▁op 0.44482421875
i 0.400634765625
ates 0.0015192031860351562
, 9.34375
▁medical 4.16015625
▁mar 0.0277252197265625
iju 0.0005850791931152344
ana 2.777576446533203e-05
, 0.197021484375
▁and 0.09234619140625
▁mixed 1.6171875
▁OP 11.40625
MM 4.171875
▁groups 0.544921875
▁number 9.3203125
ed 0.019927978515625
▁ 0.1668701171875
5 1.7265625
7 2.6328125
. 0.5
1 2.5234375
%, 0.19287109375
▁ 0.0032958984375
2 1.84375
2 2.65625
. 0.10565185546875
3 2.267578125
%, 0.053009033203125
▁and 0.055572509765625
▁ 0.0017681121826171875
5 2.126953125
1 2.0859375
. 0.1558837890625
4 1.9072265625
%, 0.15966796875
▁respectively 0.0204315185546875
. 0.2578125
▁The 1.150390625
▁pl 3.845703125
ur 0.00806427001953125
ality 5.459785461425781e-05
▁of 0.0218963623046875
▁anx 0.43994140625
iety 0.01508331298828125
▁contained 10.9140625
▁ 0.236328125
4 1.125
8 2.359375
. 0.17138671875
4 2.1953125
% 1.96875
▁among 2.56640625
▁OP 5.3203125
▁patients 5.953125
, 0.26904296875
▁ 0.0821533203125
2 0.95263671875
1 2.517578125
. 0.1099853515625
5 2.11328125
% 0.0222625732421875
▁among 0.462646484375
▁MM 0.09954833984375
▁patients 0.33349609375
, 0.01788330078125
▁and 0.0135955810546875
▁ 0.0245361328125
3 1.369140625
8 1.9140625
. 0.1295166015625
7 2.193359375
% 0.01142120361328125
▁among 0.194580078125
▁OP 1.9990234375
MM 0.12359619140625
▁participants 3.251953125
. 0.22705078125
▁Pat 4.65625
ients 0.0165557861328125
▁who 1.912109375
▁took 2.181640625
▁strong 9.6171875
▁op 0.65380859375
i 0.8056640625
ates 0.002819061279296875
▁were 1.2734375
▁t 10.3125
ended 1.06640625
▁to 0.0074920654296875
▁place 9.75
▁their 1.998046875
▁pain 0.98681640625
▁on 1.880859375
▁a 0.57373046875
▁scale 1.8828125
▁of 0.39697265625
▁ 0.113037109375
9 2.501953125
▁to 2.203125
▁ 0.01100921630859375
1 0.004390716552734375
0 0.004718780517578125
▁( 2.77734375
Fe 1.6416015625
ing 0.0020923614501953125
old 0.00036978721618652344
▁et 0.01548004150390625
▁al 0.0015726089477539062
., 0.01030731201171875
▁ 0.001499176025390625
2 0.0001798868179321289
0 3.0279159545898438e-05
1 0.0016002655029296875
7 0.006855010986328125
). 0.01068878173828125
▁They 3.515625
▁were 1.740234375
▁also 1.1240234375
▁an 9.6796875
gu 4.58984375
ished 0.06683349609375
▁em 5.9609375
otion 0.0006146430969238281
ally 0.0006089210510253906
▁and 1.1572265625
▁react 7.42578125
ed 0.0217742919921875
▁rad 9.21875
ically 0.0009551048278808594
▁neg 4.63671875
atively 0.001110076904296875
▁to 0.1795654296875
▁almost 5.4453125
▁all 1.6357421875
▁survey 3.79296875
▁questions 0.203369140625
. 0.310791015625
▁Pat 2.8046875
ients 0.0045013427734375
▁who 1.1328125
▁took 1.6337890625
▁only 4.59765625
▁MM 0.395751953125
▁or 2.94140625
▁mixed 2.458984375
▁medic 1.4912109375
ations 0.2301025390625
▁course 13.7578125
▁had 2.44921875
▁a 1.34765625
▁significantly 2.7890625
▁more 3.4140625
▁stable 2.5078125
▁emot 0.77783203125
ional 0.0008111000061035156
▁state 0.54931640625
▁and 1.24609375
▁cop 6.7265625
ed 0.030548095703125
▁with 0.345458984375
▁pain 0.86181640625
▁more 1.8603515625
▁manage 6.91796875
able 1.576171875
. 0.268798828125
▁One 5.48828125
▁of 0.437744140625
▁the 0.0074005126953125
▁major 2.943359375
▁limitations 3.05078125
▁is 3.435546875
▁the 0.5322265625
▁ins 4.703125
u 0.0673828125
fficient 0.095947265625
ly 3.552734375
▁high 3.078125
▁response 3.12890625
▁rate 0.09783935546875
, 2.74609375
▁ 4.22265625
5 1.7529296875
7 2.677734375
% 2.294921875
▁instead 6.1640625
▁of 0.0027332305908203125
▁ 0.493408203125
7 1.837890625
0 0.4765625
% 1.509765625
▁( 2.3203125
Fe 0.66650390625
ing 0.0014467239379882812
old 0.00027871131896972656
▁et 0.01128387451171875
▁al 0.0009322166442871094
., 0.006748199462890625
▁ 0.0015106201171875
2 0.0001004934310913086
0 8.64267349243164e-05
1 0.0004227161407470703
7 0.002285003662109375
). 0.011138916015625
▁It 1.9921875
▁can 3.330078125
▁be 0.66552734375
▁fairly 8.1953125
▁explained 1.998046875
▁by 0.2041015625
▁the 0.273681640625
▁weak 7.4609375
▁focus 7.0
▁of 0.66357421875
▁respond 5.9453125
ents 0.1051025390625
▁who 3.6953125
▁have 3.833984375
▁overcome 8.234375
▁severe 2.00390625
▁pain 0.4912109375
▁sens 7.73828125
ations 0.1983642578125
▁and 0.95556640625
▁de 4.82421875
press 0.74560546875
ive 0.039947509765625
▁episodes 2.232421875
. 0.446533203125
▁It 2.78125
▁is 0.55322265625
▁not 2.51171875
▁clear 3.615234375
▁how 1.9326171875
▁to 3.326171875
▁use 5.14453125
▁these 2.79296875
▁statistics 3.96484375
, 3.064453125
▁as 0.6689453125
▁they 1.91015625
▁still 5.25390625
▁may 5.16796875
▁be 1.2060546875
▁relevant 6.33984375
▁for 1.8193359375
▁the 1.912109375
▁overall 4.7578125
▁analysis 2.5625
. 0.818359375
